Stockscreener 앱 받기
3.84
3.50%
0.13
전일 마감가:
$3.71
열려 있는:
$3.69
하루 거래량:
173.94K
Relative Volume:
0.91
시가총액:
$197.24M
수익:
$63.69M
순이익/손실:
$-44.82M
주가수익비율:
-1.92
EPS:
-2
순현금흐름:
$-30.56M
1주 성능:
+17.79%
1개월 성능:
+14.29%
6개월 성능:
+74.55%
1년 성능:
+92.96%
1일 변동 폭
$3.65
$3.98
1주일 범위
$3.00
$3.98
52주 변동 폭
$1.35
$5.33
Mdxhealth Sa Stock (MDXH) Company Profile
MDXH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
3.84 | 190.56M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
618.72 | 234.69B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.99 | 169.45B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
715.37 | 56.86B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
237.68 | 41.09B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
139.64 | 41.06B | 6.95B | 1.30B | 1.15B | 4.5696 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-17 | 개시 | Craig Hallum | Buy |
| 2024-10-31 | 개시 | Lake Street | Buy |
| 2023-05-31 | 개시 | TD Cowen | Outperform |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
Mdxhealth Sa 주식(MDXH)의 최신 뉴스
Analysts Expect Breakeven For MDxHealth SA (NASDAQ:MDXH) Before Long - Sahm
MDxHealth SA (NASDAQ:MDXH) Sees Significant Increase in Short Interest - MarketBeat
Retail Surge: How interest rate cuts could boost MDxHealth SA stockSwing Trade & Community Trade Idea Sharing Platform - Bộ Nội Vụ
MDxHealth Posts Preliminary 2025 Results, Expects Revenue Growth Of 26% To 28% In 2026 - Nasdaq
MDxHealth reports 23% revenue growth in Q4, issues 2026 guidance By Investing.com - Investing.com India
MDxHealth Sees Over 20% Revenue Growth in Q4, Full Year - Orange County Business Journal
MDxHealth reports 23% revenue growth in Q4, issues 2026 guidance - Investing.com
MDXH Projects Strong Revenue Growth and Ambitious 2026 Targets - GuruFocus
MDxHealth sees Q4 revenue $30.5M, consensus $26.18M - TipRanks
MDxHealth Posts Strong 2025 Revenue Growth, Sets 2026 Outlook and Revises Exact Sciences Earnout - TipRanks
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences - The Manila Times
Precision diagnostics company MDxHealth maps 2026 growth and new Exact deal - Stock Titan
MDxHealth (NASDAQ:MDXH) and Biotricity (OTCMKTS:BTCY) Critical Survey - Defense World
How MDxHealth SA stock reacts to job market data2025 Geopolitical Influence & Technical Entry and Exit Tips - ulpravda.ru
Will MDxHealth SA stock attract ESG investors2025 Big Picture & Proven Capital Preservation Methods - ulpravda.ru
Analyst Downgrade: How MDxHealth SA stock reacts to inflationary pressures2025 Pullback Review & High Yield Equity Trading Tips - Улправда
Is MDxHealth SA stock dividend yield sustainableWeekly Market Report & Consistent Income Trade Ideas - Улправда
How MDxHealth SA stock reacts to inflationary pressuresTrade Analysis Summary & AI Forecast for Swing Trade Picks - Улправда
Can MDxHealth SA stock resist sector downturnsJuly 2025 Fed Impact & Capital Protection Trade Alerts - Улправда
MDxHealth announces next phase of collab with University of Oxford - MSN
Loss-Making MDxHealth SA (NASDAQ:MDXH) Expected To Breakeven In The Medium-Term - Yahoo Finance
MDxHealth SAOrdinary Shares (NQ: MDXH - FinancialContent
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer - The Manila Times
World’s largest prostate cancer trial adds genomic test to guide care - Stock Titan
MDxHealth SA (NASDAQ:MDXH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
MDxHealth Files to Sell Up to $200 Million in Shares - marketscreener.com
MDxHealth SA to offer securities up to $200 millionSEC filing - marketscreener.com
MDxHealth SA (NASDAQ:MDXH) Short Interest Update - MarketBeat
Setup Watch: Will MDxHealth SA stock continue dividend increasesWeekly Trend Recap & Expert Verified Movement Alerts - Bộ Nội Vụ
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), MDxHealth (MDXH) and RxSight (RXST) - The Globe and Mail
MDXH: BTIG Reiterates Buy Rating with $7 Price Target | MDXH Sto - GuruFocus
BTIG reiterates Buy rating on MDxHealth stock, maintains $7 price target By Investing.com - Investing.com South Africa
BTIG Research Reaffirms "Buy" Rating for MDxHealth (NASDAQ:MDXH) - MarketBeat
BTIG reiterates Buy rating on MDxHealth stock, maintains $7 price target - Investing.com Australia
How MDxHealth SA stock benefits from tech adoptionMarket Sentiment Review & Capital Efficient Trading Techniques - Улправда
Why MDxHealth SA stock remains undervalued2025 Valuation Update & Weekly Watchlist for Consistent Profits - Улправда
Is MDxHealth SA stock overvalued by current metricsJuly 2025 Setups & Advanced Technical Signal Analysis - Улправда
Retail Surge: How MDxHealth SA stock benefits from tech adoptionJuly 2025 Intraday Action & Weekly Setup with ROI Potential - Улправда
Why MDxHealth SA stock is a must watch in 20252025 Growth vs Value & AI Powered Market Entry Ideas - DonanımHaber
Reviewing 111 (NASDAQ:YI) & MDxHealth (NASDAQ:MDXH) - Defense World
MDxHealth SA (NASDAQ:MDXH) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
MDxHealth management to meet virtually with BTIG - MSN
MDxHealth price target raised to $7 from $5 at TD Cowen - MSN
MDXH: Upcoming Virtual Meeting Hosted by BTIG - GuruFocus
Samjo Management LLC Sells 96,718 Shares of MDxHealth SA $MDXH - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough - simplywall.st
MDxHealth SA's (NASDAQ:MDXH) market cap touched US$182m last week, benefiting both individual investors who own 46% as well as institutions - simplywall.st
Mdxhealth Sa (MDXH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.51%
0.74%
자본화:
|
볼륨(24시간):